TEVOGEN BIO HLDGS INC COM - Stock (LGST)

CUSIP: G8028L107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Stock
Total 13F shares
4,790,721
Share change
-29,403,009
Total reported value
$51,550,176
Price per share
$10.78
Number of holders
5
Value change
-$303,753,935
Number of buys
3
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP G8028L107?
CUSIP G8028L107 identifies LGST - TEVOGEN BIO HLDGS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVOGEN BIO HLDGS INC COM - Stock (LGST) as of Q1 2023

As of 31 Mar 2023, TEVOGEN BIO HLDGS INC COM - Stock (LGST) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,790,721 shares. The largest 5 holders included Corbin Capital Partners, L.P., FourWorld Capital Management LLC, CANTOR FITZGERALD, L. P., UBS Group AG, and MORGAN STANLEY. This page lists 5 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.